Tender Details
Beyond this tender, use our platform to source any product, service, or solution.
Get direct quotes or register as a qualified provider.
| Particulars | Details |
|---|---|
| Title |
A M I No 11.01/2025 26 Tab/Cap.Alpha Ketoanalouge 100mg
|
| Description |
For Complete Deion And Other Details, Please Refer To Tender
|
| Organisation | Ministry of Railways | Central Govt. Ministry/Department |
| Tender Id | 106564102 |
|
Reference Number |
82243471C |
| Tender Fee | 0 |
| EMD | 0 |
| Tender Value | - |
| Place | New Delhi |
| Link |
View Original Tender Notice
https://www.ireps.gov.in/ireps/supply/pdfdocs/012025/106564102/viewNitPdf_4821390.pdf |
| Start Date | January 01, 2025 20:39 |
| End Date |
Expired
13/01/2025
Expired 631 days ago |
Tender Support
Get help with filing, GeM registration, documents, or relevant tender alerts.
A m i no- 11.01/2025-26 tab/cap.alphaketoanalouge 100mg
For complete deion and other details, please refer to tender
Read moreA m i no. 2025-26 tab./cap. lorlatinib 100mg
For complete deion and other details, please refer to tender
Read moreA m i no. 12.208 / 2025-26 tab./cap. canagliflozin 100mg
For complete deion and other details, please refer to tender
Read moreA m i no - 12.257/2025-26 tab/cap sitagliptin 100mg
For complete deion and other details, please refer to tender
Read moreA m i no. 11.01 / 2024-25 alphaketoanalouge
For complete deion and other details, please refer to tender
Read moreA m i no - 16.57/2025-26 oxaliplatin inj 100mg
For complete deion and other details, please refer to tender
Read moreA m i no. 16.63 / 2025-26 panitumumab inj 100mg
For complete deion and other details, please refer to tender
Read moreA m i no - 16.64/-2025-26 pembrolizumab inj 100mg
For complete deion and other details, please refer to tender
Read moreA m i no-18.11/2025-26 inj thiamine 100mg per ml
For complete deion and other details, please refer to tender
Read moreA m i no - 16.243/2025-26 tab./cap.osimertinib 80mg
For complete deion and other details, please refer to tender
Read moreof your Industry type